3M EPAQ CFC-FREE ALBUTEROL MDI IS COMPARABLE TO VENTOLIN, ADVISORY COMMITTEE CONCLUDES; PHASE IV STUDIES SHOULD DEFINE POTENCY, EFFECT OF SPACERS
Executive Summary
3M Pharmaceuticals' chlorofluorocarbon-free albuterol metered-dose inhaler Epaq is clinically comparable to Glaxo Wellcome's albuterol MDI Ventolin, which uses a CFC propellant, FDA's Pulmonary-Allergy Drugs Advisory Committee concurred March 29.